BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 18850694)

  • 1. Compound I in heme thiolate enzymes: a comparative QM/MM study.
    Cho KB; Hirao H; Chen H; Carvajal MA; Cohen S; Derat E; Thiel W; Shaik S
    J Phys Chem A; 2008 Dec; 112(50):13128-38. PubMed ID: 18850694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In silico design of a mutant of cytochrome P450 containing selenocysteine.
    Cohen S; Kumar D; Shaik S
    J Am Chem Soc; 2006 Mar; 128(8):2649-53. PubMed ID: 16492051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of substrate, protein environment, and proximal ligand mutation on compound I and compound 0 of chloroperoxidase.
    Lai W; Chen H; Cho KB; Shaik S
    J Phys Chem A; 2009 Oct; 113(43):11763-71. PubMed ID: 19572690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantum mechanical/molecular mechanical study on the mechanisms of compound I formation in the catalytic cycle of chloroperoxidase: an overview on heme enzymes.
    Chen H; Hirao H; Derat E; Schlichting I; Shaik S
    J Phys Chem B; 2008 Aug; 112(31):9490-500. PubMed ID: 18597525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What is the active species of cytochrome P450 during camphor hydroxylation? QM/MM studies of different electronic states of compound I and of reduced and oxidized iron-oxo intermediates.
    Altun A; Shaik S; Thiel W
    J Am Chem Soc; 2007 Jul; 129(29):8978-87. PubMed ID: 17595079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. QM/MM modeling of compound I active species in cytochrome P450, cytochrome C peroxidase, and ascorbate peroxidase.
    Harvey JN; Bathelt CM; Mulholland AJ
    J Comput Chem; 2006 Sep; 27(12):1352-62. PubMed ID: 16788912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic QM/MM investigation of factors that affect the cytochrome P450-catalyzed hydrogen abstraction of camphor.
    Altun A; Shaik S; Thiel W
    J Comput Chem; 2006 Sep; 27(12):1324-37. PubMed ID: 16788908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New features in the catalytic cycle of cytochrome P450 during the formation of compound I from compound 0.
    Kumar D; Hirao H; de Visser SP; Zheng J; Wang D; Thiel W; Shaik S
    J Phys Chem B; 2005 Oct; 109(42):19946-51. PubMed ID: 16853579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the bound substrate in nitric oxide synthase protonated or neutral and what is the active oxidant that performs substrate hydroxylation?
    de Visser SP; Tan LS
    J Am Chem Soc; 2008 Oct; 130(39):12961-74. PubMed ID: 18774806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. QM/MM study of mechanisms for compound I formation in the catalytic cycle of cytochrome P450cam.
    Zheng J; Wang D; Thiel W; Shaik S
    J Am Chem Soc; 2006 Oct; 128(40):13204-15. PubMed ID: 17017800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compound I of nitric oxide synthase: the active site protonation state.
    Cho KB; Derat E; Shaik S
    J Am Chem Soc; 2007 Mar; 129(11):3182-8. PubMed ID: 17319660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toward identification of the compound I reactive intermediate in cytochrome P450 chemistry: a QM/MM study of its EPR and Mössbauer parameters.
    Schöneboom JC; Neese F; Thiel W
    J Am Chem Soc; 2005 Apr; 127(16):5840-53. PubMed ID: 15839682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of substrate on the spectral properties of oxyferrous wild-type and T252A cytochrome P450-CAM.
    Sono M; Perera R; Jin S; Makris TM; Sligar SG; Bryson TA; Dawson JH
    Arch Biochem Biophys; 2005 Apr; 436(1):40-9. PubMed ID: 15752707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electronic structure of compound I in human isoforms of cytochrome P450 from QM/MM modeling.
    Bathelt CM; Zurek J; Mulholland AJ; Harvey JN
    J Am Chem Soc; 2005 Sep; 127(37):12900-8. PubMed ID: 16159284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active species of horseradish peroxidase (HRP) and cytochrome P450: two electronic chameleons.
    de Visser SP; Shaik S; Sharma PK; Kumar D; Thiel W
    J Am Chem Soc; 2003 Dec; 125(51):15779-88. PubMed ID: 14677968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gauging the relative oxidative powers of compound I, ferric-hydroperoxide, and the ferric-hydrogen peroxide species of cytochrome P450 toward C-H hydroxylation of a radical clock substrate.
    Derat E; Kumar D; Hirao H; Shaik S
    J Am Chem Soc; 2006 Jan; 128(2):473-84. PubMed ID: 16402834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of redox potential and alteration in reactivity via the peroxide shunt pathway by mutation of cytochrome P450 around the proximal heme ligand.
    Matsumura H; Wakatabi M; Omi S; Ohtaki A; Nakamura N; Yohda M; Ohno H
    Biochemistry; 2008 Apr; 47(16):4834-42. PubMed ID: 18363338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NR transfer reactivity of azo-compound I of P450. How does the nitrogen substituent tune the reactivity of the species toward C-H and C=C activation?
    Moreau Y; Chen H; Derat E; Hirao H; Bolm C; Shaik S
    J Phys Chem B; 2007 Aug; 111(34):10288-99. PubMed ID: 17676893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electron transfer activation of chromopyrrolic acid by cytochrome p450 en route to the formation of an antitumor indolocarbazole derivative: theory supports experiment.
    Wang Y; Hirao H; Chen H; Onaka H; Nagano S; Shaik S
    J Am Chem Soc; 2008 Jun; 130(23):7170-1. PubMed ID: 18481854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Principal active species of horseradish peroxidase, compound I: a hybrid quantum mechanical/molecular mechanical study.
    Derat E; Cohen S; Shaik S; Altun A; Thiel W
    J Am Chem Soc; 2005 Oct; 127(39):13611-21. PubMed ID: 16190726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.